SCHEMBL2843987

SCHEMBL2843987

COc1ccc(C=CC(=O)Nc2ccccc2C(=O)O)cn1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 8/20 0.69
NPC1 O15118 4/20 0.69
RAB9A P51151 4/20 0.69
MAPT P10636 4/20 0.69
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
SMN1; SMN2 Q16637 3/20 0.69
ALDH1A1 P00352 3/20 0.65
TP53 P04637 2/20 0.65
CYP3A4 P08684 2/20 0.65
HPGD P15428 2/20 0.65
HIF1A Q16665 2/20 0.65
CYP1A2 P05177 1/20 0.65
CYP2C9 P11712 1/20 0.65
CYP2C19 P33261 1/20 0.65
HSD17B10 Q99714 1/20 0.65
KDM4E B2RXH2 1/20 0.65
ABCC4 O15439 1/20 0.65
HPGDS O60760 1/20 0.65
ABCB11 O95342 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2843981 1.00 TRPA1 (0.69) TRPA1NPC1RAB9AMAPTMEN1
SCHEMBL15396795 0.84 TRPM2 (0.64) TRPA1NPC1RAB9AMAPTMEN1
SCHEMBL9606901 0.84 NPC1 (0.59) TRPA1NPC1RAB9AMAPTMEN1
SCHEMBL2849664 0.82 TRPA1 (1.00) TRPA1NPC1RAB9AMAPTMEN1
SCHEMBL2849668 0.82 TRPA1 (1.00) TRPA1NPC1RAB9AMAPTMEN1
Tranilast SCHEMBL8696829 0.79 MEN1 (1.00) TRPA1NPC1RAB9AMAPTMEN1
Tranilast SCHEMBL29876 0.79 MEN1 (1.00) TRPA1NPC1RAB9AMAPTMEN1
Tranilast SCHEMBL29556872 0.79 MEN1 (1.00) TRPA1NPC1RAB9AMAPTMEN1
Tranilast SCHEMBL30053800 0.79 MEN1 (1.00) TRPA1NPC1RAB9AMAPTMEN1
Tranilast SCHEMBL29875 0.79 MEN1 (1.00) TRPA1NPC1RAB9AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2799427-B1 Therapeutic compounds FIBROTECH THERAPEUTICS PTY LTD (AU) 2018-07-04 EP disclosed
US-9561201-B2 Therapeutic compounds FIBROTECH THERAPEUTICS PTY LTD (AU) 2017-02-07 US disclosed
US-20140357628-A1 THERAPEUTIC COMPOUNDS FIBROTECH THERAPEUTICS PTY LTD (AU) 2014-12-04 US disclosed
EP-2799427-A1 Therapeutic compounds Fibrotech Therapeutics PTY LTD (AU) 2014-11-05 EP disclosed
US-8765812-B2 Therapeutic compounds FIBROTECH THERAPEUTICS PTY LTD (AU) 2014-07-01 US disclosed
EP-2035369-B1 THERAPEUTIC COMPOUNDS FIBROTECH THERAPEUTICS PTY LTD (AU) 2014-06-25 EP disclosed
CN-101600683-B Therapeutic compounds FIBROTECH THERAPEUTICS PTY LTD AU 2013-06-12 CN disclosed
US-20100130497-A1 Therapeutic Compounds FIBROTECH THERAPEUTICS PTY LTD (AU) 2010-05-27 US disclosed
CN-101600683-A Therapeutic compounds FIBROTECH THERAPEUTICS PTY LTD (AU) 2009-12-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140357628-A1 THERAPEUTIC COMPOUNDS NFATC1, AADAC, NAT1 TRPA1 78/4885NPC1 1199/4885RAB9A 1097/4885
US-20100130497-A1 Therapeutic Compounds NFATC1, NAT1, AADAC TRPA1 87/4885NPC1 1318/4885RAB9A 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.